The novel immunotoxin HM1.24-ETA′ induces apoptosis in multiple myeloma cells

Despite new treatment modalities, the clinical outcome in a substantial number of patients with multiple myeloma (MM) has yet to be improved. Antibody-based targeted therapies for myeloma patients could make use of the HM1.24 antigen (CD317), a surface molecule overexpressed on malignant plasma cell...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Staudinger, M, Glorius, P, Burger, R, Kellner, C, Klausz, K, Günther, A, Repp, R, Klapper, W, Gramatzki, M, Peipp, M
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2014
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4080209/
https://ncbi.nlm.nih.gov/pubmed/24927408
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bcj.2014.38
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items